Related Stories GLP-1 weight-loss drugs may also reduce binge eating Semaglutide fuels rapid growth in US GLP-1RA use as payments rise Study links GLP-1 treatment to fewer alcohol drinking days In comparison to composite control, GLP-1RA use exhibited a decreased risk of 34 outcomes, including pneumonia, respiratory failure, alcohol use disorders, COPD, and suicidal ideation, and an increased risk of 17 outcomes, including abdominal pain, GERD, nephrolithiasis, and sleep disturbances
External resources ScienceDirect: Impact of injection sites on subcutaneous peptide pharmacokinetics NEJM: Once-weekly semaglutide in adults with overweight or obesity For researchers serious about optimizing every aspect of their GLP-1 protocol, SeekPeptides offers the most comprehensive resource available, with evidence-based injection guides, personalized protocol builders, and a community of thousands who have navigated these exact questions
This is in contrast to someone who loses weight via exercise exercise tends to increase VO2max
The best choice depends on your specific situation
